DRUG · Unmapped registry intervention
All licensed antiretroviral medications
Find medicine records ·
Find other trials using this name
Clinical trial
Strategic Timing of Antiretroviral Treatment
NCT00867048
Study summary
ClinicalTrials.govStrategic Timing of Antiretroviral Treatment
Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE4
Loading study purpose, treatment groups and outcomes…
View the complete registry record, eligibility and contacts at ClinicalTrials.gov
Drugs and interventions used in this trial
1 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
No matching interventions in this trial.
Advertisement
Conditions
HIV Infectionverified · MONDO: HIV infectious disease
Interventions
Sponsors & collaborators
University of Minnesotalead sponsor
Copenhagen HIV Programmecollaborator
Medical Research Councilcollaborator
Kirby Institutecollaborator
Washington D.C. Veterans Affairs Medical Centercollaborator
ANRS, Emerging Infectious Diseasescollaborator
NEAT - European AIDS Treatment Networkcollaborator
National Cancer Institute (NCI)collaborator
National Institute of Mental Health (NIMH)collaborator
Abbottcollaborator
Bristol-Myers Squibbcollaborator
Gilead Sciencescollaborator
GlaxoSmithKlinecollaborator
Merck Sharp & Dohme LLCcollaborator
Tibotec Pharmaceutical Limitedcollaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT00867048 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.